Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 48, Issue 5, Pages 713-715Publisher
OXFORD UNIV PRESS
DOI: 10.1093/jac/48.5.713
Keywords
-
Ask authors/readers for more resources
Micafungin (FK-463), a member of the new candin family of antifungal agents, was highly active against clinical isolates of Candida albicans and Candida dubliniensis. The in vitro activity of micafungin suggested that it was more potent than fluconazole, flucytosine, amphotericin B or voriconazole against C. albicans, and comparable or moderately less effective against C. dubliniensis isolates when high-resolution medium (HR) was used. Lower MICs of micafungin were recorded when RPMI 2% or AM3 2% media were used, indicating an influence of the growth medium on the MIC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available